DGX— QUEST DIAGNOSTICS INC

Health Care$26.2B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Net revenues	$11.04B+11.8%	$9.87B+6.7%	$9.25B-6.4%	$9.88B
Cost of services	$7.37B+11.2%	$6.63B+6.9%	$6.20B-3.9%	$6.45B
Selling, general and administrative	$1.97B+11.1%	$1.77B+7.8%	$1.64B-12.4%	$1.87B
Amortization of intangible assets	$154.0M+21.3%	$127.0M+17.6%	$108.0M-10.0%	$120.0M
Other operating (income) expense, net	-$12.0M-1300.0%	$1.0M-97.6%	$41.0M+272.7%	$11.0M
Total operating costs and expenses, net	$9.48B+11.2%	$8.53B+6.7%	$7.99B-5.5%	$8.46B
Operating income	$1.56B+15.6%	$1.35B+6.7%	$1.26B-11.6%	$1.43B
Interest expense, net	-$264.0M-31.3%	-$201.0M-32.2%	-$152.0M-10.1%	-$138.0M
Other Nonoperating Income (Expense)	$26.0M-13.3%	$30.0M+50.0%	$20.0M+136.4%	-$55.0M
Total non-operating expense, net	-$238.0M-39.2%	-$171.0M-29.5%	-$132.0M+31.6%	-$193.0M
Income before income taxes and equity in earnings of equity method investees	$1.32B+12.2%	$1.18B+4.0%	$1.13B-8.5%	$1.24B
Income tax expense	-$314.0M-15.0%	-$273.0M-10.1%	-$248.0M+6.1%	-$264.0M
Equity in earnings of equity method investees, net of taxes	$42.0M+121.1%	$19.0M-26.9%	$26.0M-40.9%	$44.0M
Net income	$1.05B+13.6%	$921.0M+1.4%	$908.0M-10.5%	$1.01B
Less: Net income attributable to noncontrolling interests	$54.0M+8.0%	$50.0M-7.4%	$54.0M-21.7%	$69.0M
Net income attributable to Quest Diagnostics	$992.0M+13.9%	$871.0M+2.0%	$854.0M-9.7%	$946.0M
Basic (in dollars per share)	$8870000.00+14.0%	$7780000.00+2.5%	$7590000.00-6.3%	$8100000.00
Diluted (in dollars per share)	$8750000.00+13.8%	$7690000.00+2.7%	$7490000.00-6.0%	$7970000.00

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.